• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 2.06% 49.5¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives grant from US Department of Defence

Announcements


RCE Appendix 4EPRICE SENSITIVE28/08/20 download Created with Sketch. 209.81KB
RCE Recce Pharmaceuticals Appoints James Graham as CEOPRICE SENSITIVE28/08/20 download Created with Sketch. 370.03KB
RCE Appointment of H. Pylori Expert Prof Sutton to Dev Program21/08/20 download Created with Sketch. 342.2KB
RCE Conversion of Performance Shares17/08/20 download Created with Sketch. 343.59KB
RCE Investor Presentation04/08/20 download Created with Sketch. 3.87MB
RCE Positive Oral Data on New RECCE 435 Against H. pyloriPRICE SENSITIVE04/08/20 download Created with Sketch. 757.45KB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE31/07/20 download Created with Sketch. 476.79KB
RCE Opening Address at 2020 World Antibiotic Resistance Congress23/07/20 download Created with Sketch. 409.52KB
RCE Correction - CSIRO SARS-CoV-2 Antiviral Screening Program20/07/20 download Created with Sketch. 189.13KB
RCE US Researchers to Test RECCE in Expanded SARS-CoV-2 ProgramPRICE SENSITIVE16/07/20 download Created with Sketch. 330.61KB
RCE Pause in TradingPRICE SENSITIVE16/07/20 download Created with Sketch. 115.78KB
RCE Initial Director's Interest Notice14/07/20 download Created with Sketch. 158.61KB
RCE Recce Adds Biotech Veteran Alan W. Dunton M.D. to its Board14/07/20 download Created with Sketch. 300.96KB
RCE Change of Director's Interest Notice13/07/20 download Created with Sketch. 215.41KB
RCE Change of Director's Interest Notice13/07/20 download Created with Sketch. 216.37KB
RCE Change in substantial holding13/07/20 download Created with Sketch. 245.99KB
RCE Cleansing Statement09/07/20 download Created with Sketch. 198.45KB
RCE Appendix 2A09/07/20 download Created with Sketch. 152.57KB
RCE Reinstatement to Official QuotationPRICE SENSITIVE08/07/20 download Created with Sketch. 403.6KB
RCE RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral ProgramPRICE SENSITIVE08/07/20 download Created with Sketch. 355KB
RCE Suspension from Official QuotationPRICE SENSITIVE08/07/20 download Created with Sketch. 332.13KB
RCE Trading HaltPRICE SENSITIVE06/07/20 download Created with Sketch. 465.73KB
RCE Pause in TradingPRICE SENSITIVE06/07/20 download Created with Sketch. 115.4KB
RCE Final Director's Interest Notice03/07/20 download Created with Sketch. 189.99KB
RCE Resignation of Director & CRO Dr. Graham Melrose03/07/20 download Created with Sketch. 319.73KB
RCE Conversion of Performance Shares26/06/20 download Created with Sketch. 306.34KB
RCE Response to ASX Price and Volume QueryPRICE SENSITIVE27/05/20 download Created with Sketch. 306.58KB
RCE Cleansing Statement21/05/20 download Created with Sketch. 177.66KB
RCE Appendix 2A21/05/20 download Created with Sketch. 39.78KB
RCE Corporate Presentation - May 202021/05/20 download Created with Sketch. 3.22MB
RCE Positive Data on RECCE 327 Against Neisseria gonorrhoeaePRICE SENSITIVE04/05/20 download Created with Sketch. 452.72KB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE29/04/20 download Created with Sketch. 400.44KB
RCE Further Positive Data on RECCE 327 Against MRSA SuperbugPRICE SENSITIVE23/04/20 download Created with Sketch. 875.14KB
RCE Positive Data on RECCE 327 Against Influenza APRICE SENSITIVE20/04/20 download Created with Sketch. 573.09KB
RCE Trading HaltPRICE SENSITIVE16/04/20 download Created with Sketch. 272.42KB
RCE Recce Signs Phase I Human Clinical Trial AgreementPRICE SENSITIVE08/04/20 download Created with Sketch. 269.15KB
RCE First-in-Human Clinical Trial Progress UpdatePRICE SENSITIVE17/03/20 download Created with Sketch. 337.38KB
RCE Cleansing Statement27/02/20 download Created with Sketch. 177.66KB
RCE Appendix 2A27/02/20 download Created with Sketch. 323.8KB
RCE Half Yearly Report and AccountsPRICE SENSITIVE27/02/20 download Created with Sketch. 387.4KB
RCE Positive Efficacy Data in Kidney/UTI infections animal modelPRICE SENSITIVE14/02/20 download Created with Sketch. 551.41KB
RCE Positive Data from RECCE 327 Antibiotic Safety StudiesPRICE SENSITIVE10/02/20 download Created with Sketch. 966.57KB
RCE Appendix 4C and CommentaryPRICE SENSITIVE31/01/20 download Created with Sketch. 883.85KB
RCE Cleansing Statement16/01/20 download Created with Sketch. 177.89KB
RCE Appendix 2A16/01/20 download Created with Sketch. 274.3KB
RCE Change of Director's Interest Notice20/12/19 download Created with Sketch. 267.69KB
RCE Change of Director's Interest Notice19/12/19 download Created with Sketch. 224.41KB
RCE Cleansing Statement19/12/19 download Created with Sketch. 243.32KB
RCE Appendix 3B19/12/19 download Created with Sketch. 113.31KB
RCE Corporate Presentation - December 201904/12/19 download Created with Sketch. 2.58MB
RCE Constitution29/11/19 download Created with Sketch. 605.86KB
RCE Positive Data for RECCE 327 in MRSA Burns Wound InfectionPRICE SENSITIVE27/11/19 download Created with Sketch. 712.48KB
RCE Results of Meeting25/11/19 download Created with Sketch. 181.59KB
RCE Trading HaltPRICE SENSITIVE25/11/19 download Created with Sketch. 276.11KB
RCE Opening Address at 2019 World Antibiotic Resistance Congress08/11/19 download Created with Sketch. 2.84MB
RCE Appendix 4C and CommentaryPRICE SENSITIVE31/10/19 download Created with Sketch. 850.63KB
RCE Notice of Annual General Meeting/Proxy Form25/10/19 download Created with Sketch. 1.65MB
RCE White Paper on Recce Synthetic Polymer Antibiotics23/10/19 download Created with Sketch. 2.64MB
RCE Change in substantial holding16/10/19 download Created with Sketch. 250.41KB
RCE Cleansing Statement16/10/19 download Created with Sketch. 211.16KB
RCE Notice under ASX Listing Rule 3.10.5A16/10/19 download Created with Sketch. 186.03KB
RCE Appendix 3B16/10/19 download Created with Sketch. 397.59KB
RCE Recce Completes Raising of $6.76 millionPRICE SENSITIVE10/10/19 download Created with Sketch. 244.08KB
RCE Trading HaltPRICE SENSITIVE08/10/19 download Created with Sketch. 421.91KB
RCE Results of Meeting30/09/19 download Created with Sketch. 179.22KB
RCE Appendix 4G27/09/19 download Created with Sketch. 145.28KB
RCE 2019 Annual Report27/09/19 download Created with Sketch. 11.56MB
RCE Key Family 2 Patent Granted in Japan for RECCE AntibioticsPRICE SENSITIVE20/09/19 download Created with Sketch. 238.51KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE18/09/19 download Created with Sketch. 273.07KB
RCE Funding UpdatePRICE SENSITIVE11/09/19 download Created with Sketch. 240.9KB
RCE Investor Presentation - September 201910/09/19 download Created with Sketch. 4.03MB
RCE Appendix 4E - Preliminary Final ReportPRICE SENSITIVE30/08/19 download Created with Sketch. 310.09KB
RCE Notice of General Meeting/Proxy Form30/08/19 download Created with Sketch. 1.54MB
RCE Government Grant for University and Industry Collaboration30/08/19 download Created with Sketch. 249.41KB
RCE FDA Positive Response for Recce Scaled Manufacture & QualityPRICE SENSITIVE26/08/19 download Created with Sketch. 253.13KB
RCE Response to ASX Appendix 4C QueryPRICE SENSITIVE16/08/19 download Created with Sketch. 745.16KB
RCE Change of Director's Interest Notice14/08/19 download Created with Sketch. 372.09KB
RCE Change of Director's Interest Notice08/08/19 download Created with Sketch. 224.49KB
RCE Key Family 2 Patent Granted in Europe for RECCE AntibioticsPRICE SENSITIVE08/08/19 download Created with Sketch. 239.06KB
RCE Opening R&D Address at World Antibiotic Resistance CongressPRICE SENSITIVE01/08/19 download Created with Sketch. 570.79KB
RCE Appendix 4C and commentaryPRICE SENSITIVE30/07/19 download Created with Sketch. 767.78KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE30/07/19 download Created with Sketch. 170.61KB
RCE Initial Director's Interest Notice12/07/19 download Created with Sketch. 156.32KB
RCE Appointment of Independent Chair and Additional DirectorPRICE SENSITIVE09/07/19 download Created with Sketch. 280.92KB
RCE Leading Physician to Chair Clinical Advisory Committee03/06/19 download Created with Sketch. 217.64KB
RCE R&D Incentive Rebate Received01/05/19 download Created with Sketch. 241.11KB
RCE Appendix 4C and commentaryPRICE SENSITIVE29/04/19 download Created with Sketch. 487.15KB
RCE Investor Presentation - April 201910/04/19 download Created with Sketch. 2.4MB
RCE USA Patent Granted for Recce's AntibioticsPRICE SENSITIVE14/03/19 download Created with Sketch. 213.86KB
RCE Change of Director's Interest Notice07/03/19 download Created with Sketch. 359.01KB
RCE Half Yearly Report and AccountsPRICE SENSITIVE27/02/19 download Created with Sketch. 363.14KB
RCE Change in substantial holding15/02/19 download Created with Sketch. 306.38KB
RCE Change of Director's Interest Notice15/02/19 download Created with Sketch. 222.36KB
RCE Cleansing Statement15/02/19 download Created with Sketch. 234.66KB
RCE Notice under ASX Listing Rule 3.10.5A15/02/19 download Created with Sketch. 219.65KB
RCE Issue of Securities and Appendix 3B15/02/19 download Created with Sketch. 473.94KB
RCE Recce Successfully Raises $1.8 million via PlacementPRICE SENSITIVE08/02/19 download Created with Sketch. 296.72KB
RCE Trading HaltPRICE SENSITIVE06/02/19 download Created with Sketch. 272.95KB
RCE Appendix 4C and commentaryPRICE SENSITIVE31/01/19 download Created with Sketch. 672.92KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE31/01/19 download Created with Sketch. 218.33KB
RCE Appendix 4E
28/08/20PRICE SENSITIVE download Created with Sketch. 209.81KB
RCE Recce Pharmaceuticals Appoints James Graham as CEO
28/08/20PRICE SENSITIVE download Created with Sketch. 370.03KB
RCE Appointment of H. Pylori Expert Prof Sutton to Dev Program
21/08/20 download Created with Sketch. 342.2KB
RCE Conversion of Performance Shares
17/08/20 download Created with Sketch. 343.59KB
RCE Investor Presentation
04/08/20 download Created with Sketch. 3.87MB
RCE Positive Oral Data on New RECCE 435 Against H. pylori
04/08/20PRICE SENSITIVE download Created with Sketch. 757.45KB
RCE Appendix 4C and Activity Report
31/07/20PRICE SENSITIVE download Created with Sketch. 476.79KB
RCE Opening Address at 2020 World Antibiotic Resistance Congress
23/07/20 download Created with Sketch. 409.52KB
RCE Correction - CSIRO SARS-CoV-2 Antiviral Screening Program
20/07/20 download Created with Sketch. 189.13KB
RCE US Researchers to Test RECCE in Expanded SARS-CoV-2 Program
16/07/20PRICE SENSITIVE download Created with Sketch. 330.61KB
RCE Pause in Trading
16/07/20PRICE SENSITIVE download Created with Sketch. 115.78KB
RCE Initial Director's Interest Notice
14/07/20 download Created with Sketch. 158.61KB
RCE Recce Adds Biotech Veteran Alan W. Dunton M.D. to its Board
14/07/20 download Created with Sketch. 300.96KB
RCE Change of Director's Interest Notice
13/07/20 download Created with Sketch. 215.41KB
RCE Change of Director's Interest Notice
13/07/20 download Created with Sketch. 216.37KB
RCE Change in substantial holding
13/07/20 download Created with Sketch. 245.99KB
RCE Cleansing Statement
09/07/20 download Created with Sketch. 198.45KB
RCE Appendix 2A
09/07/20 download Created with Sketch. 152.57KB
RCE Reinstatement to Official Quotation
08/07/20PRICE SENSITIVE download Created with Sketch. 403.6KB
RCE RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program
08/07/20PRICE SENSITIVE download Created with Sketch. 355KB
RCE Suspension from Official Quotation
08/07/20PRICE SENSITIVE download Created with Sketch. 332.13KB
RCE Trading Halt
06/07/20PRICE SENSITIVE download Created with Sketch. 465.73KB
RCE Pause in Trading
06/07/20PRICE SENSITIVE download Created with Sketch. 115.4KB
RCE Final Director's Interest Notice
03/07/20 download Created with Sketch. 189.99KB
RCE Resignation of Director & CRO Dr. Graham Melrose
03/07/20 download Created with Sketch. 319.73KB
RCE Conversion of Performance Shares
26/06/20 download Created with Sketch. 306.34KB
RCE Response to ASX Price and Volume Query
27/05/20PRICE SENSITIVE download Created with Sketch. 306.58KB
RCE Cleansing Statement
21/05/20 download Created with Sketch. 177.66KB
RCE Appendix 2A
21/05/20 download Created with Sketch. 39.78KB
RCE Corporate Presentation - May 2020
21/05/20 download Created with Sketch. 3.22MB
RCE Positive Data on RECCE 327 Against Neisseria gonorrhoeae
04/05/20PRICE SENSITIVE download Created with Sketch. 452.72KB
RCE Appendix 4C and Activity Report
29/04/20PRICE SENSITIVE download Created with Sketch. 400.44KB
RCE Further Positive Data on RECCE 327 Against MRSA Superbug
23/04/20PRICE SENSITIVE download Created with Sketch. 875.14KB
RCE Positive Data on RECCE 327 Against Influenza A
20/04/20PRICE SENSITIVE download Created with Sketch. 573.09KB
RCE Trading Halt
16/04/20PRICE SENSITIVE download Created with Sketch. 272.42KB
RCE Recce Signs Phase I Human Clinical Trial Agreement
08/04/20PRICE SENSITIVE download Created with Sketch. 269.15KB
RCE First-in-Human Clinical Trial Progress Update
17/03/20PRICE SENSITIVE download Created with Sketch. 337.38KB
RCE Cleansing Statement
27/02/20 download Created with Sketch. 177.66KB
RCE Appendix 2A
27/02/20 download Created with Sketch. 323.8KB
RCE Half Yearly Report and Accounts
27/02/20PRICE SENSITIVE download Created with Sketch. 387.4KB
RCE Positive Efficacy Data in Kidney/UTI infections animal model
14/02/20PRICE SENSITIVE download Created with Sketch. 551.41KB
RCE Positive Data from RECCE 327 Antibiotic Safety Studies
10/02/20PRICE SENSITIVE download Created with Sketch. 966.57KB
RCE Appendix 4C and Commentary
31/01/20PRICE SENSITIVE download Created with Sketch. 883.85KB
RCE Cleansing Statement
16/01/20 download Created with Sketch. 177.89KB
RCE Appendix 2A
16/01/20 download Created with Sketch. 274.3KB
RCE Change of Director's Interest Notice
20/12/19 download Created with Sketch. 267.69KB
RCE Change of Director's Interest Notice
19/12/19 download Created with Sketch. 224.41KB
RCE Cleansing Statement
19/12/19 download Created with Sketch. 243.32KB
RCE Appendix 3B
19/12/19 download Created with Sketch. 113.31KB
RCE Corporate Presentation - December 2019
04/12/19 download Created with Sketch. 2.58MB
RCE Constitution
29/11/19 download Created with Sketch. 605.86KB
RCE Positive Data for RECCE 327 in MRSA Burns Wound Infection
27/11/19PRICE SENSITIVE download Created with Sketch. 712.48KB
RCE Results of Meeting
25/11/19 download Created with Sketch. 181.59KB
RCE Trading Halt
25/11/19PRICE SENSITIVE download Created with Sketch. 276.11KB
RCE Opening Address at 2019 World Antibiotic Resistance Congress
08/11/19 download Created with Sketch. 2.84MB
RCE Appendix 4C and Commentary
31/10/19PRICE SENSITIVE download Created with Sketch. 850.63KB
RCE Notice of Annual General Meeting/Proxy Form
25/10/19 download Created with Sketch. 1.65MB
RCE White Paper on Recce Synthetic Polymer Antibiotics
23/10/19 download Created with Sketch. 2.64MB
RCE Change in substantial holding
16/10/19 download Created with Sketch. 250.41KB
RCE Cleansing Statement
16/10/19 download Created with Sketch. 211.16KB
RCE Notice under ASX Listing Rule 3.10.5A
16/10/19 download Created with Sketch. 186.03KB
RCE Appendix 3B
16/10/19 download Created with Sketch. 397.59KB
RCE Recce Completes Raising of $6.76 million
10/10/19PRICE SENSITIVE download Created with Sketch. 244.08KB
RCE Trading Halt
08/10/19PRICE SENSITIVE download Created with Sketch. 421.91KB
RCE Results of Meeting
30/09/19 download Created with Sketch. 179.22KB
RCE Appendix 4G
27/09/19 download Created with Sketch. 145.28KB
RCE 2019 Annual Report
27/09/19 download Created with Sketch. 11.56MB
RCE Key Family 2 Patent Granted in Japan for RECCE Antibiotics
20/09/19PRICE SENSITIVE download Created with Sketch. 238.51KB
RCE R&D Incentive Rebate Received
18/09/19PRICE SENSITIVE download Created with Sketch. 273.07KB
RCE Funding Update
11/09/19PRICE SENSITIVE download Created with Sketch. 240.9KB
RCE Investor Presentation - September 2019
10/09/19 download Created with Sketch. 4.03MB
RCE Appendix 4E - Preliminary Final Report
30/08/19PRICE SENSITIVE download Created with Sketch. 310.09KB
RCE Notice of General Meeting/Proxy Form
30/08/19 download Created with Sketch. 1.54MB
RCE Government Grant for University and Industry Collaboration
30/08/19 download Created with Sketch. 249.41KB
RCE FDA Positive Response for Recce Scaled Manufacture & Quality
26/08/19PRICE SENSITIVE download Created with Sketch. 253.13KB
RCE Response to ASX Appendix 4C Query
16/08/19PRICE SENSITIVE download Created with Sketch. 745.16KB
RCE Change of Director's Interest Notice
14/08/19 download Created with Sketch. 372.09KB
RCE Change of Director's Interest Notice
08/08/19 download Created with Sketch. 224.49KB
RCE Key Family 2 Patent Granted in Europe for RECCE Antibiotics
08/08/19PRICE SENSITIVE download Created with Sketch. 239.06KB
RCE Opening R&D Address at World Antibiotic Resistance Congress
01/08/19PRICE SENSITIVE download Created with Sketch. 570.79KB
RCE Appendix 4C and commentary
30/07/19PRICE SENSITIVE download Created with Sketch. 767.78KB
RCE R&D Incentive Rebate Received
30/07/19PRICE SENSITIVE download Created with Sketch. 170.61KB
RCE Initial Director's Interest Notice
12/07/19 download Created with Sketch. 156.32KB
RCE Appointment of Independent Chair and Additional Director
09/07/19PRICE SENSITIVE download Created with Sketch. 280.92KB
RCE Leading Physician to Chair Clinical Advisory Committee
03/06/19 download Created with Sketch. 217.64KB
RCE R&D Incentive Rebate Received
01/05/19 download Created with Sketch. 241.11KB
RCE Appendix 4C and commentary
29/04/19PRICE SENSITIVE download Created with Sketch. 487.15KB
RCE Investor Presentation - April 2019
10/04/19 download Created with Sketch. 2.4MB
RCE USA Patent Granted for Recce's Antibiotics
14/03/19PRICE SENSITIVE download Created with Sketch. 213.86KB
RCE Change of Director's Interest Notice
07/03/19 download Created with Sketch. 359.01KB
RCE Half Yearly Report and Accounts
27/02/19PRICE SENSITIVE download Created with Sketch. 363.14KB
RCE Change in substantial holding
15/02/19 download Created with Sketch. 306.38KB
RCE Change of Director's Interest Notice
15/02/19 download Created with Sketch. 222.36KB
RCE Cleansing Statement
15/02/19 download Created with Sketch. 234.66KB
RCE Notice under ASX Listing Rule 3.10.5A
15/02/19 download Created with Sketch. 219.65KB
RCE Issue of Securities and Appendix 3B
15/02/19 download Created with Sketch. 473.94KB
RCE Recce Successfully Raises $1.8 million via Placement
08/02/19PRICE SENSITIVE download Created with Sketch. 296.72KB
RCE Trading Halt
06/02/19PRICE SENSITIVE download Created with Sketch. 272.95KB
RCE Appendix 4C and commentary
31/01/19PRICE SENSITIVE download Created with Sketch. 672.92KB
RCE R&D Incentive Rebate Received
31/01/19PRICE SENSITIVE download Created with Sketch. 218.33KB
(20min delay)
Last
49.5¢
Change
0.010(2.06%)
Mkt cap ! $114.6M
Open High Low Value Volume
48.5¢ 51.0¢ 48.5¢ $1.909K 3.908K

Buyers (Bids)

No. Vol. Price($)
4 15775 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 66869 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
Last
49.0¢
  Change
0.010 ( 1.01 %)
Open High Low Volume
50.0¢ 50.0¢ 49.0¢ 28935
Last updated 15.32pm 30/08/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.